CCooper Companies operates in two main areas: CooperVision and CooperSurgical. CooperVision makes a wide range of contact lenses to correct vision, supported by product development, manufacturing, and global distribution. CooperSurgical offers medical devices, fertility, and genomic products for women’s health, covering care from contraception through advanced reproductive treatments, with a vertically integrated model that controls research, development, manufacturing, and distribution. Compared with competitors, the company combines vision care and women’s health in one group and maintains end-to-end control of its product lifecycle, enabling integrated supply and service delivery to healthcare providers and patients worldwide. Its goal is to improve health outcomes for people through accessible contact lenses and comprehensive women’s health products and services, across the globe.
Work here?Claim your company
Industries
Company Size
201-500
Company Stage
IPO
Headquarters
San Ramon, CA
Founded
1958
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Lost money on The Cooper Companies, Inc. shares? The Law Offices of Frank R. Cruz continues investigating potential securities fraud after 14.67% stock decline. Investigation centers on the September 9, 2026 news about The Cooper Companies, Inc.; investors with losses may have potential claims to recover them. LOS ANGELES, Oct. 29, 2026 (GLOBE NEWSWIRE) - The Cooper Companies, Inc. ("CooperCompanies" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz continues investigating potential securities fraud claims on behalf of investors in The Cooper Companies, Inc. (NASDAQ: COO), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about The Cooper Companies, Inc. on September 9, 2026. If you lost money on The Cooper Companies, Inc. securities, share your The Cooper Companies, Inc. loss information with the firm to learn about potentially pursuing a claim to recover your losses. The Cooper Companies, Inc. investigation at a glance * Date of disclosure: September 9, 2026 * Share price decline: $9.31 per share, or 14.67% * Closing price: $54.17 on September 10, 2026 What happened? On September 9, 2026, Cooper Companies announced third quarter 2026 results. Among other things, the Company "reported revenue of $717 million, essentially flat year-over-year" and stated that "the results in the Americas reflected CooperVision's U.S. channel inventory reductions." The Company further stated that it "proactively reduced U.S. channel inventory that weighed on our results and will continue to impact Q4." Cooper also lowered its full-year guidance, explaining that "the entire reason for the reduction in the revenue guidance for CooperVision was tied to just channel inventory." Revenue guidance was reduced by approximately 1.4%, or $59.5 million at the midpoint, to $4.24 billion, while EPS guidance was reduced by approximately 1.8%, or $0.09 at the midpoint, to a range of $4.51 to $4.55. On this news, Cooper Companies shares declined $9.31 or 14.67% per share, to close at $54.17 on September 10, 2026, thereby injuring investors. "The Cooper Companies, Inc. shares dropped 14.67% after it was disclosed on September 9, 2026 that Cooper Companies' revenue was flat and it had cut its full-year guidance due to U.S. channel inventory reductions. Our investigation will look at whether investors had complete and accurate information before that disclosure," said Frank R. Cruz of The Law Offices of Frank R. Cruz. What should The Cooper Companies, Inc. investors do now? The Law Offices of Frank R. Cruz is investigating potential claims on behalf of The Cooper Companies, Inc. investors. Investors who lost money can visit the Cooper Companies, Inc. investigation page, email [email protected], or call 310-914-5007. If you inquire by email, please include your mailing address, telephone number, and number of shares purchased. Questions and answers about the Cooper Companies, Inc. investigation Who is eligible? Investors who purchased The Cooper Companies, Inc. securities and suffered losses may have claims, and can contact the firm to find out whether the Cooper Companies, Inc. investigation affects them. What does a securities fraud investigation involve? In the Cooper Companies, Inc. investigation, The Law Offices of Frank R. Cruz is examining whether the Company or its executives may have made false or misleading statements to investors in violation of the federal securities laws. Is there a lawsuit? This release announces an investigation by The Law Offices of Frank R. Cruz, not a lawsuit. If a securities class action is later filed against The Cooper Companies, Inc., investors may be able to seek appointment as lead plaintiff. How are attorneys' fees handled? The Law Offices of Frank R. Cruz works on contingency, so The Cooper Companies, Inc. investors pay no attorneys' fees up front. Any attorneys' fees and litigation expenses come only from a recovery, if there is one, and require court approval. Information for whistleblowers Anyone with non-public information about The Cooper Companies, Inc. should consider their options to assist the investigation or participate in the SEC Whistleblower Program. The program allows whistleblowers who provide original information leading to a successful SEC enforcement action to receive awards of 10 to 30 percent of the sanctions collected, when those sanctions exceed $1 million. For more information, contact Frank R. Cruz at 310-914-5007 or email [email protected]. About The Law Offices of Frank R. Cruz The Law Offices of Frank R. Cruz investigates and prosecutes securities fraud and corporate malfeasance class actions. With nearly 20 years of litigation experience, the firm focuses on complex securities class actions and gives each client personal, one-on-one attention throughout the legal process. Prior results do not guarantee a similar outcome. The Law Offices of Frank R. Cruz Los Angeles, CA Email: [email protected] Telephone: 310-914-5007 Follow The Law Offices of Frank R. Cruz for updates on Twitter: twitter.com/FRC_LAW
Cooper Companies swaps out its CEO after A rough patch. CEO Al White stepped down immediately, with board member Walt Rosebrough running day-to-day operations as the company reaffirmed its fiscal 2026 forecast. about 3 hours ago - 2 mins What's going on here? The Cooper Companies replaced its CEO on Tuesday, with Al White stepping down immediately and board member Walt Rosebrough taking over day-to-day leadership while the medical device maker searches for a permanent chief. What does this mean? Cooper said the abrupt switch is about execution: Rosebrough, a former STERIS CEO who joined the board in January, said results "have not met our expectations" and the board needed to move fast. The company is trying to balance "reset" with continuity: White is leaving the board but will remain a strategic adviser through April 2027, while Rosebrough serves as executive chair and interim operator. Investors tend to flinch at sud... Keep reading for free. This content is free, but you must be logged in to continue reading. Already have an account?
CooperCompanies named independent director Walt Rosebrough executive chair and said chief executive officer Albert White III is stepping down, effective immediately. Rosebrough will oversee daily operations until a permanent chief executive is appointed. White will stay on as a strategic advisor through April 1, 2027. The medical device maker has hired search firm Russell Reynolds. Rosebrough said recent performance "has not met our expectations." Former Johnson & Johnson executive Shlomi Nachman will join the board as an independent director on December 8, 2026. Directors Barbara Carbone, Colleen Jay, and Robert Weiss will not stand for reelection at the 2027 annual meeting, leaving a seven-member board. The company reaffirmed its fiscal 2026 guidance.
Cooper Companies CEO White steps down; board member Rosebrough named executive chair. By Thomson Reuters Oct 27, 2026 | 5:21 PM Oct 27 (Reuters) - Cooper Companies said on Tuesday CEO Al White had stepped down, effective immediately, and board member Walt Rosebrough was elected executive chair as the medical device maker begins a search for a new CEO. Shares of the California-based company fell nearly 3% in extended trading. - Rosebrough, an independent director who joined the board in January and is the former CEO of STERIS, will oversee day-to-day operations until a permanent chief executive is appointed - Rosebrough said recent performance "has not met our expectations" and warranted decisive action by the board - White, who is also leaving the board, will remain with the company as a strategic adviser through April 2027 - Additionally, Shlomi Nachman, a former Johnson & Johnson executive with experience in medical devices and vision care, will join the board as an independent director, effective December 8, Cooper said - Three current board members, Barbara Carbone, Colleen Jay and Robert Weiss, will not stand for re-election at the company's 2027 annual shareholder meeting, it added - The company reaffirmed its fiscal 2026 forecast issued on September 9, including annual adjusted earnings of $4.51 to $4.55 per share (Reporting by Siddhi Mahatole in Bengaluru; Editing by Shreya Biswas)
The Cooper Companies has opened The Vision Centre, a global innovation hub in Southampton, England, to accelerate contact lens development for its CooperVision business. The facility integrates research and development, clinical expertise, pilot manufacturing and commercial capabilities under one roof. CooperVision announced six product advancements across myopia control, silicone hydrogel, toric and multifocal contact lenses, with launches planned over coming years. The pipeline includes a complete family of one-day contact lenses for myopia control and a premium one-day silicone hydrogel technology. Following the announcement, COO stock gained 1.4%. Year to date, shares have declined 31.6% against the industry's 2.8% growth. The company has a market capitalisation of $10.51 billion. CooperVision's products currently reach more than 40 million people worldwide.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
201-500
Company Stage
IPO
Headquarters
San Ramon, CA
Founded
1958
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs